stella
beta
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma — Stella
Recruiting
Back to Cutaneous Melanoma trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Trial locations
(2 sites)
United States
University of Iowa, Iowa City, Iowa
Huntsman Cancer Institute, Salt Lake City, Utah
View full record on ClinicalTrials.gov